An investor is suing the biopharmaceutical company Geron Corp., its officers, and executive leadership for alleged violations of federal securities laws.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback